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Translesion synthesis DNA 
polymerase η exhibits a specific 
RNA extension activity and a 
transcription-associated function
Vamsi K. Gali1,3, Eva Balint  1, Nataliia Serbyn2, Orsolya Frittmann1, Francoise Stutz2 &  
Ildiko Unk1
Polymerase eta (Polη) is a low fidelity translesion synthesis DNA polymerase that rescues damage-
stalled replication by inserting deoxy-ribonucleotides opposite DNA damage sites resulting in error-
free or mutagenic damage bypass. In this study we identify a new specific RNA extension activity of 
Polη of Saccharomyces cerevisiae. We show that Polη is able to extend RNA primers in the presence of 
ribonucleotides (rNTPs), and that these reactions are an order of magnitude more efficient than the 
misinsertion of rNTPs into DNA. Moreover, during RNA extension Polη performs error-free bypass of 
the 8-oxoguanine and thymine dimer DNA lesions, though with a 103 and 102–fold lower efficiency, 
respectively, than it synthesizes opposite undamaged nucleotides. Furthermore, in vivo experiments 
demonstrate that the transcription of several genes is affected by the lack of Polη, and that Polη is 
enriched over actively transcribed regions. Moreover, inactivation of its polymerase activity causes 
similar transcription inhibition as the absence of Polη. In summary, these results suggest that the new 
RNA synthetic activity of Polη can have in vivo relevance.
When DNA replication is blocked by DNA lesions, DNA damage tolerance (DDT) mechanisms are activated 
that can sustain replication on damaged templates without removing the damage. One mechanism of DDT is 
translesion synthesis (TLS), where specialized DNA polymerases synthesize across the damage and/or extend 
from it1. TLS polymerases can be found in all three domains of life. They display lowered selectivity and fidelity 
compared to replicative polymerases due to their large active center and to their lack of a proofreading activity. 
Their non-selective active center can accommodate damaged and modified bases enabling them to perform TLS. 
Damage bypass can be error-free or error-prone depending on whether the correct or an incorrect nucleotide is 
inserted opposite a lesion. Error-free bypass contributes to genomic stability, whereas error-prone damage bypass 
increases instability by causing mutagenesis. The RAD30-encoded TLS DNA polymerase Polη of Saccharomyces 
cerevisiae can bypass several DNA lesions in a faithful or mutagenic manner. It stands out among other polymer-
ases by its unique ability to efficiently and accurately bypass cyclobutane pyrimidine dimers (CPDs), the most 
frequent UV-induced DNA lesions2. It can do so because its active center can accommodate both nucleotides of 
the dimer3. Polη can also bypass efficiently and error-freely 8-oxoguanine (8-oxoG), one of the most abundant 
spontaneous oxidative lesions, whereas replicative DNA polymerases carry out mostly error-prone bypass of 
this damage4. Though Polη is highly error-prone on non-damaged DNA, its inactivation in yeast cells and in 
mouse cell lines increases the UV-induced mutation rate5–7, while in humans it causes a cancer-prone syndrome, 
the variant form of xeroderma pigmentosum8,9. These findings indicate that the main in vivo function of Polη 
is non-mutagenic and its activity is mostly restricted to damage sites. The distributive mode of DNA synthesis 
by Polη, that dissociates from DNA after inserting only a few nucleotides, probably also serves to confine its 
activity10. Polη can get access to the stalled replication fork through its interaction with proliferating cell nuclear 
antigen (PCNA), the processivity clamp of the replicative DNA polymerases11,12. The interaction with PCNA is 
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essential for the in vivo function of Polη, as mutations disrupting this interaction cause the same phenotype in 
yeast as the complete lack of Polη11.
DNA polymerases use deoxy-ribonucleotides (dNTPs) when synthesizing DNA, despite the much higher 
cellular concentration of ribonucleotides (rNTPs). It was discovered that a specific amino acid, called the “steric 
gate”, is responsible for exclusion of rNTPs from the active site of DNA polymerases13–15. However, the exclusion 
is not complete and even the major replicative DNA polymerases have been shown to insert rNTPs during DNA 
synthesis with varying low frequency16–20. The presence of ribonucleotides in the genome is destabilizing21, and is 
counteracted by ribonucleotide excision repair that efficiently removes ribonucleotides from the genomic DNA22.
In this study we show that Polη is inefficient in inserting rNTPs during DNA synthesis, but unexpectedly, it 
has the specific activity to extend RNA strands with ribonucleotides. Moreover, Polη can mediate RNA TLS dur-
ing RNA extension with the same fidelity as it does during DNA synthesis, although with very low efficiencies. 
Polη can also insert dNTPs into RNA, and it does so with similar efficiencies as with rNTPs at nucleotide concen-
trations estimating the in vivo conditions. Moreover, damage bypass by Polη is more efficient with dNTPs during 
RNA extension. Nevertheless, Polη is required for the efficient transcription of several genes in vivo and is physi-
cally associated with the open reading frame of the actively transcribed GAL1 gene. Furthermore, we demonstrate 
that the polymerase activity of Polη is required for its transcription-associated function in vivo. Based on our 
findings we propose a role for the discovered new RNA synthetic activity of Polη during transcription.
Results
Polη has the specific activity to extend RNA strands with ribonucleotides. We examined whether 
Polη could use rNTPs when synthesizing DNA, by performing in vitro primer extension assays in the presence 
of purified recombinant Polη (Fig. 1a). The activity of Polη was confirmed in control DNA extension reactions in 
the presence of dNTPs (Fig. 1b). When rNTPs were added to the reactions instead of dNTPs, Polη was still able to 
extend the DNA primer using ribonucleotides (Fig. 1b). Although this extension was very inefficient and required 
high enzyme concentrations, Polη could synthesize a ribonucleotide chain on the DNA primer using rNTPs, as 
indicated by the appearance of lower mobility bands on the gel. Thus, the terminal ribonucleotide did not inhibit 
further synthesis and Polη was able to extend not only a terminal deoxy-ribonucleotide, but also a terminal ribo-
nucleotide containing primer. This prompted us to investigate the ribonucleotide chain extension ability of Polη 
in reactions containing a DNA template hybridized with an RNA primer in the presence of rNTPs. Importantly, 
these experiments demonstrated that Polη was able to extend an RNA primer with rNTPs and to catalyze the 
formation of a polyribonucleotide chain (Fig. 1c). The absence of any polymerase activity when using the catalyt-
ically inactive Polη D30A mutant in these assays confirmed that both the DNA and RNA synthetic activities are 
intrinsic to Polη (Fig. 1d). Notably, the extension of a primer with dNTPs or rNTPs results in slightly different 
electrophoretic mobility; it can therefore be ruled out that the observed activity results from contamination of the 
rNTPs by dNTPs (Fig. 1b last two rows, and Fig. S2).
Polη seemed rather inefficient in RNA extension with rNTPs as opposed to DNA extension with dNTPs. For 
example, at 11 nM enzyme concentration Polη extended nearly all the DNA primers in the reaction with dNTPs, 
whereas almost no insertion of rNTPs into RNA could be observed at the same enzyme concentration (compare 
Fig. 1b and c). However, the applied 100 µM dNTP concentration was much higher than the intracellular dNTP 
level that ranges from 12–30 µM, and vice versa, the applied 100 µM rNTP concentration was much lower than 
the intracellular rNTP level of 0.5–3 mM16. To clarify whether the RNA extension ability of Polη reflected a spe-
cific activity or was the result of misinsertion, we performed steady-state kinetic analysis where we compared the 
efficiency of rNTP incorporation by Polη into RNA versus DNA. Remarkably, Polη extended RNA primers with 
rNTPs an order of magnitude more efficiently than DNA primers, except in the case of rATP (Fig. 2 compare a 
to e, b to f, c to g, and d to h; Tables 1 and 2). For example, Polη incorporated rGTP into RNA ~30, and rCTP 
~20 times more efficiently than into DNA, whereas rUTP incorporation into DNA was so weak that it was not 
measurable (Fig. 2h). Significantly, the Km values for RNA extension with single rNTPs were in the range of the 
intracellular concentrations of rNTPs suggesting that the activity might have an in vivo relevance. In summary, 
these results show that Polη recognizes RNA as its substrate and that rNTP incorporation into RNA is specific and 
not merely misincorporation due to the not-so-stringent active center of Polη.
Polη can extend RNA with deoxy-ribonucleotides. Next we investigated whether Polη selectively 
inserted rNTPs during RNA synthesis, or whether dNTP misinsertion could also occur. For this reason we 
applied single dNTPs in the RNA primer extension reactions and determined the kinetic parameters of the reac-
tions (Fig. 3 and Table 3). As our steady-state kinetic assays showed, the Kcat/Km values for dNTP insertions were 
much higher compared to rNTP insertions indicating that dNTP insertions were more effective. However, when 
we took into consideration the big difference between the in vivo concentrations of dNTPs and rNTPs, the relative 
frequencies were around 1 (Table 3) meaning that at physiological dNTP and rNTP concentrations Polη inserts 
dNTPs and rNTPs into RNA with similar efficiencies.
Polη can perform error-free bypass of an 8-oxoG and a TT dimer during RNA extension. The 
main identified cellular function of Polη is to promote DNA replication through DNA damages by inserting 
dNTPs opposite to damage sites. To test whether it exhibits similar activity during RNA extension, we examined 
Polη damage bypass ability in vitro using an 8-oxoG, or a TT dimer containing oligonucleotide. We chose these 
DNA lesions because Polη was already shown to bypass them efficiently and in an error free manner during 
DNA synthesis2,4. We confirmed that Polη can bypass these DNA lesions during DNA synthesis with dNTPs 
(Fig. 4a and f). Furthermore, Polη was able to extend the RNA primer opposite an 8-oxoG (Fig. 4b) and a TT 
dimer (Fig. 4g) with rNTPs. More importantly, even when high 4 mM single rNTP concentrations were included 
in the reactions, it inserted only CTP opposite 8-oxoG (Fig. 4c) and only ATP opposite the TT dimer (Fig. 4h). 
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Figure 1. Polη can catalyze DNA and RNA extension with rNTPs. (a) Purity of recombinant Polη and 
Polη D30A. 200 ng of each protein was analyzed on 8% denaturing SDS-polyacrylamide gel. Molecular 
mass standards are shown on the left. (b) Polη can perform DNA primer extension with dNTPs and rNTPs. 
Reactions were carried out using 24 nM template and increasing concentrations of Polη, as indicated at the 
bottom, in the presence of 100 μM dNTP or rNTP for 5 min. (c) Polη can catalyze RNA primer extension with 
ribonucleotides. Reactions contained 16 nM template and 100 µM rNTP and were incubated for 10 min. (d) 
Polη D30A is defective in both DNA and RNA primer extensions. Reactions were incubated with wild-type or 
mutant Polη (140 nM), in the presence of 100 µM of either dNTPs (left panel) or rNTPs (right panel) for 10 min. 
The structures of the substrates are shown at the top of each panel. Asterisks mark the 5′ Cy3 labeled ends. See 
Fig. S1 for full-length images.
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Figure 2. Steady-state kinetic analysis of RNA and DNA primer extensions with rNTPs by Polη. RNA primer 
extension with (a) rATP, (b) rCTP, (c) rGTP, (d) rUTP is shown on the left. DNA primer extension with 
(e) rATP, (f) rCTP, (g) rGTP, (h) rUTP is shown on the right. Polη (1 nM) was incubated with 20 nM of the 
indicated templates in the presence of increasing concentrations of the single incoming rNTP, as shown under 
the gel pictures. The quenched samples were analyzed by denaturing polyacrylamide gel electrophoresis, and 
quantified as described (see Materials and Methods). For each rNTP the rate of incorporation is plotted as 
a function of rNTP concentrations. The data were fit to the Michaelis-Menten equation (see Materials and 
Methods). In panel (h) incorporation of rUTP was so weak that it could not be quantified. See Fig. S3 for full-
length images.
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The result showing 2 rNTP insertions opposite 8-oxoG, but only 1 opposite the undamaged C (Fig. 4b) is in 
good agreement with the observation that Polη is more processive on damaged DNA23. The weak intensity of the 
bands in Fig. 4g corresponding to multiple insertions is probably due to the applied lower enzyme/template ratio. 
In summary, these results show that Polη bypasses 8-oxoG and TT dimer in an error-free manner during RNA 
synthesis by inserting only the corresponding correct rNTPs opposite the lesions.
Polη can bypass DNA damage with dNTPs during RNA extension. Next we checked the efficiencies 
of the bypass reactions by kinetic analysis applying the single correct incoming rNTPs (Fig. 4d and i, and Fig. S6). 
For both 8-oxoG and TT dimer bypass we obtained very low Kcat/Km values, 1000 times and 100 times lower 
numbers than measured on undamaged templates, respectively, reflecting the inefficient nature of the reactions 
Substrate Sequence
S1 /5C y3/CGCTACCTAGCCTGCCTCAAGAGTTGCTCG  3′-GCGATGGATCGGACGGAGTTCTCAACGAGCACAGGCTTACGCTCAGGTCG-5′
S2 /5C y3/CGCTACCTAGCCTGCCTCAAGAGTTGCTCG  3′-GCGATGGATCGGACGGAGTTCTCAACGAGCTCAGGCTTACGCTCAGGTCG-5′
S3 /5C y3/CGCTACCTAGCCTGCCTCAAGAGTTGCTCG  3′-GCGATGGATCGGACGGAGTTCTCAACGAGCGCAGGCTTACGCTCAGGTCG-5′
S4 /5C y3/CGCTACCTAGCCTGCCTCAAGAGTTGCTCG  3′-GCGATGGATCGGACGGAGTTCTCAACGAGCCCAGGCTTACGCTCAGGTCG-5′
S5 /5Cy 3/CGCUACCUAGCCUGCCUCAAGAGUUGCUCG    3′-GCGATGGATCGGACGGAGTTCTCAACGAGCACAGGCTTACGCTCAGGTCG-5′
S6 /5Cy3/CGCUACCUAGCCUGCCUCAAGAGUUGCUCG     3′-GCGATGGATCGGACGGAGTTCTCAACGAGCTCAGGCTTACGCTCAGGTCG-5′
S7 /5Cy 3/CGCUACCUAGCCUGCCUCAAGAGUUGCUCG   3′-GCGATGGATCGGACGGAGTTCTCAACGAGCGCAGGCTTACGCTCAGGTCG-5′
S8 /5Cy 3/CGCUACCUAGCCUGCCUCAAGAGUUGCUCG    3′-GCGATGGATCGGACGGAGTTCTCAACGAGCCCAGGCTTACGCTCAGGTCG-5′
S9         /5Cy3/CGACGATGCTCCGGTACTCCAGTGTAGGCAT 3′-AAAGGGTCAGTGCTGCTACGAGGCCATGAGGTCACATCCGTAGAATGCTTAAGAA CTCCGTCCGTACCATCGA-5′
S10         /5Cy3/CGACGATGCTCCGGTACTCCAGTGTAGGCAT 3′-AAAGGGTCAGTGCTGCTACGAGGCCATGAGGTCACATCCGTA°GAATGCTTAAGAA CTCCGTCCGTACCATCGA-5′
S11       /5Cy3/CGACGAUGCUCCGGUACUCCAGUGUAGGCAU 3′-CAAAAGGGTCAGTGCTGCTACGAGGCCATGAGGTCACATCCGTAGAATGCTTAAGAA CTCCGTCCGTACCATCGA-5′
S12       /5Cy3/CGACGAUGCUCCGGUACUCCAGUGUAGGCAU 3′-CAAAAGGGTCAGTGCTGCTACGAGGCCATGAGGTCACATCCGTA°GAATGCTTAAGAA CTCCGTCCGTACCATCGA-5′
S13 /5Cy3/CGTATTCGCGCGC  3′-CGAATGGCGGTGCGTTGCGCGCGAATACG-5′
S14 /5Cy3/CGTATTCGCGCGC  3′-CGAATGGCGGTGCGT^TGCGCGCGAATACG-5′
S15 /5Cy3/CGUAUUCGCGCGC    3′-CGAATGGCGGTGCGTTGCGCGCGAATACG-5′
S16 /5Cy3/CGUAUUCGCGCGC    3′-CGAATGGCGGTGCGT^TGCGCGCGAATACG-5′
Table 1. Sequence and structure of substrates used in the in vitro primer extension assays. RNA primers are 
underlined. The Cy3 label at the 5′ end of primers is indicated. The first templating nucleotides are in bold.
Primer
Insertion 
opposite
Incoming 
riboucleotide Kcat (min-1) Km (µM) Kcat/Km
Relative 
efficiencya
RNA T ATP 0.2394 ± 0.0065 466.4 ± 47.29 5.13E-04 3.34
RNA G CTP 2.758 ± 0.06217 438.3 ± 37.52 62.9E-04 18.26
RNA C GTP 0.4487 ± 0.01485 393.7 ± 52.04 11.4E-04 30.24
RNA A UTP 0.1032 ± 0.005715 423.3 ± 90.45 2.43E-04 n.d
DNA T ATP 0.1163 ± 0.009014 757.6 ± 160 1.53E-04
DNA G CTP 0.1733 ± 0.007439 503.1 ± 68.83 3.44E-04
DNA C GTP 0.01851 ± 0.000891 491.2 ± 76.14 0.37E-04
DNA A UTP — — —
Table 2. Kinetic parameters of rNTP incorporation into DNA and RNA by Polη. Values were obtained from 
results shown in Fig. 2, and represent the mean and standard error of three experiments. Kinetic parameters 
were calculated as described in “Materials and Methods”. n.d, not determined (no insertion of UTP into DNA 
could be detected). Relative efficiency was calculated using the following equation: fext = (kcat/Km)RNA/(kcat/
Km)DNA.
www.nature.com/scientificreports/
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(Table 4). Repeating the experiments using the corresponding single dNTPs instead of rNTPs revealed that lesion 
bypass during RNA synthesis is more efficient when Polη inserts dNTPs (Fig. 4e and j, Fig. S6 and Table 4). As 
Table 4 shows, even at intracellular nucleotide concentrations both 8-oxoG and TT dimer bypass are ~19 times 
more efficient with dNTPs compared to rNTPs. In summary, these experiments indicate that although Polη is able 
to carry out error-free DNA lesion bypass during RNA extension using rNTPs, it preferentially inserts dNTPs 
opposite these lesions.
rad30Δ cells are sensitive to transcription inhibitors. To investigate whether the newly discovered 
RNA synthetic activity of Polη can have functional significance, we asked whether Polη could be linked to tran-
scription. To address this question, we first investigated the sensitivity of yeast rad30 deletion strains to the widely 
used transcription inhibitor 6-azauracil (6-AU). 6-AU depletes the cellular levels of the RNA precursors UTP and 
GTP by inhibiting IMP dehydrogenase24. Consequently, transcription elongation becomes susceptible to pertur-
bations and as a result, many elongation mutants were shown to exhibit sensitivity to the drug25–27. Surprisingly, 
rad30Δ cells showed marked sensitivity to 6-AU compared to wild-type cells (Fig. 5a). This prompted us to 
Figure 3. Steady-state kinetic analysis of RNA extension with dNTPs by Polη. Gel pictures of RNA primer 
extensions with (a) dATP, (b) dCTP, (c) dGTP, (d) dTTP are shown at the top of each panel. Polη (1 nM) 
was incubated with 24 nM of the indicated templates in the presence of increasing concentrations of the 
single incoming dNTP, as shown under the gel pictures. The quenched samples were analyzed by denaturing 
polyacrylamide gel electrophoresis, and quantified as described (see Materials and Methods). For each dNTP 
the rate of incorporation is plotted as a function of dNTP concentrations. The data were fit to the Michaelis-
Menten equation (see Materials and Methods). See Fig. S4 for full-length images.
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investigate the relationship of RAD30 to genes involved in transcription. We examined DST1 coding for the 
canonical elongation factor TFIIS, the elongation factor gene RPB9 coding for a small subunit of RNAPII, and 
SNF5 encoding a chromatin remodeler involved in transcriptional activation28–30. Whereas additional deletion 
of RAD30 did not change the 6-AU sensitivities of the dst1Δ and rpb9Δ elongation factor mutant strains, it 
further sensitized the snf5Δ strain (Fig. 5a). Similar results were obtained using mycophenolic acid (MPA), 
another inhibitor of IMP dehydrogenase (Fig. 5b)31, suggesting that the absence of Polη might cause a defect in 
transcription.
The lack of RAD30 affects inducible and constitutive gene expression. Sensitivity to 6-AU and 
MPA can be indicative of transcriptional defects, however, deletion of some genes involved in other cellular pro-
cesses also confer sensitivity to these drugs32. On the other hand, reduced transcriptional induction of the IMD2 
gene, encoding IMP dehydrogenase, by 6-AU or MPA is characteristic of genuine transcriptional mutants26. To 
define whether the observed 6-AU sensitivity of rad30Δ cells actually reflected impairment of transcription, 
we first examined the induced synthesis of the IMD2 mRNA in the presence of 6-AU by reverse transcription 
followed by real time quantitative PCR (RT-qPCR). Indeed, 60% reduction in transcription, as monitored by 
IMD2 induction, was observed in rad30Δ cells suggesting that RAD30 contributes to efficient gene expression 
(Fig. 5c). Investigation of two other commonly examined loci the galactose inducible GAL10 and GAL1 genes33,34, 
strengthened these results. As shown in Fig. 5d and Fig. S7, a ~40% decrease in the GAL10 and GAL1 mRNA lev-
els could be detected in rad30Δ cells compared to the wild-type strain. The dst1Δ and dst1Δ rad30Δ, as well as 
the rpb9Δ and rpb9Δ rad30Δ mutants exhibited comparable levels of GAL gene expression, consistent with the 
6-AU sensitivities of these strains. Next we tested whether constitutive transcription was also affected in rad30Δ 
by investigating the UBC6 and TRP3 genes whose mRNA levels were shown to be stable in wild-type cells35,36. We 
found that the expression of these genes was reduced by ~50–70% in rad30Δ cells compared to wild-type cells 
(Fig. 5e and f). Transcription levels in rad30Δ cells were also monitored by luciferase reporter assays. We meas-
ured the activity of the firefly luciferase driven from the induced GAL1 promoter and observed a ~40% decrease 
in the rad30Δ compared to the wild-type strain, whereas the decrease was ~60% in the dst1Δ mutant (Fig. 5g). 
Similarly, the activity of the renilla luciferase expressed from the strong, constitutive glyceraldehyde-3-phosphate 
dehydrogenase promoter decreased to ~50% of the wild-type level in rad30Δ cells (Fig. 5h). These results sup-
port the view that deletion of RAD30 influences transcription causing a marked decrease in the mRNA levels of 
different genes.
rad30Δ cells exhibit transcriptional defect even when DNA synthesis is inhibited. Our next aim 
was to define whether the observed transcriptional defect of rad30Δ cells could originate from the role of Polη 
in DNA synthesis. We surmised that in the absence of Polη, replication complexes could stall more frequently 
and for longer times resulting in the block of transcription; alternatively, single-stranded gaps generated by NER 
could inhibit transcription if Polη was involved in the gap-filling step. This latter assumption takes into consider-
ation the findings that the TLS DNA polymerases, mouse Polκ and yeast Polζ function in NER as well37,38. Also, 
in Escherichia coli the TLS DNA polymerase DinB was found to interact with the transcription elongation factor 
NusA39. It was suggested that NusA recruits DinB to transcription complexes stalled at single-stranded gaps 
generated by NER, where it participates in gap-filling. To investigate these possibilities, we examined a rad1Δ 
rad30Δ double mutant strain arrested in the G1 phase of the cell cycle. Under these conditions NER is inactive 
due to the lack of the Rad1 endonuclease essential for NER, and replication is inhibited by cell cycle arrest. 
Importantly, even under these conditions, rad30Δ cells displayed defects in GAL10 and GAL1 gene transcription 
similarly to the previous experiments indicating that the observed effect on transcription was independent of the 
role of Polη in replication and in repair synthesis (Fig. 5i and Fig. S7). In addition, since transcription-coupled 
NER is non-functional in the absence of Rad1, the transcriptional impairment of rad30Δ cells could not stem 
from a possible involvement of Polη in this process.
Insertion 
opposite
Incoming 
nucleotide kcat (min−1) Km (µM) kcat/Km
nucleotide 
concentrationa 
(µM)
Relative 
frequency
T dATP 15.607 ± 1.227 158.94 ± 39.16 98.19 E-03 16 1.02
T rATP 0.2394 ± 0.0065 466.4 ± 47.29 0.51 E-03 3000
G dCTP 12.085 ± 0.786 107.7 ± 24.7 112.20 E-03 14 0.52
G rCTP 2.758 ± 0.062 438.3 ± 37.52 6.29 E-03 500
C dGTP 6.9332 ± 0.2768 44.35 ± 7.92 156.31 E-03 12 2.35
C rGTP 0.4487 ± 0.0149 393.7 ± 52.04 1.14 E-03 700
A dTTP 7.5753 ± 0.5505 174.49 ± 38.01 43.41 E-03 30 3.14
A rUTP 0.1032 ± 0.0057 423.3 ± 90.45 0.24 E-03 1700
Table 3. Kinetic parameters of dNTP or rNTP incorporation into RNA by Polη. aIn vivo dNTP and rNTP 
concentrations are according to ref.14. Values were obtained from results shown in Figs 2 and 3, and represent 
the mean and standard error of at least three experiments. Relative frequency of incorporation was calculated 
using the following equation: frel = (kcat1/Km1) * [dNTP]/(kcat2/Km2) * [rNTP], where kcat1/Km1 is the value for 
dNTP incorporation and kcat2/Km2 is the one for rNTP incorporation.
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Figure 4. Polη can carry out error-free bypass of 8-oxoG and TT dimer during RNA extension. (a) Polη 
(56 nM) can synthesize through a G, and an 8-oxoG containing template (8 nM both) during DNA extension 
with dNTPs (100 µM) and (b) also during RNA extension with rNTPs (100 µM) (c) Polη (10 nM) inserts only 
the correct C (4 mM of each rNTP) opposite 8-oxoG (8 nM). (d) Kinetic assay for rCTP and (e) dCTP insertion 
opposite 8-oxoG. (f) Polη (18 nM) can synthesize through an undamaged TT and a TT dimer containing 
template (16 nM both) during DNA extension with dNTPs (100 µM), as well as (g) during RNA extension with 
rNTPs (1 mM). (h) Polη (18 nM) inserts only the correct A (4 mM of each rNTP) opposite a TT dimer (16 nM). 
(i) Kinetic assay of rATP and (j) dATP insertion opposite a TT dimer. In reactions shown in (d,e) 1 nM Polη was 
incubated with 8 nM template. In (i,j) reactions contained 1 nM Polη and 16 nM template. Conditions for the 
kinetic assays of (d,e,i,j) are detailed in Materials and Methods. The positions of the normal G or 8-oxoG (°G), 
and the two Ts or the TT dimer (TΛT) in the substrates are indicated Asterisks mark the 5′ Cy3 labeled ends. 
See Fig. S5 for full-length images.
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Deletion of RAD30 affects transcription elongation in vivo. To further corroborate the connection 
between RAD30 and transcription, we examined transcription elongation by employing the G-less-based run-on 
(GLRO) method developed for direct in vivo analysis of elongation on chromatin40. In this assay, the amount 
of nascent mRNA synthesized in the cells over a promoter distal G-less cassette is compared to the amount 
of mRNA synthesized over a promoter proximal G-less cassette, the two cassettes being separated by a long, 
G-rich sequence that is refractory to elongation (Fig. 6a). RNase T1 digestion of total cellular RNA degrades all 
G-containing sequences leaving the two G-less cassettes intact that can be visualized and measured after pol-
yacrylamide gel electrophoresis. In our hands, transcription elongation efficiency of the second cassette in the 
control spt4Δ strain, used originally to validate the method, was ~20% of the wild-type value, in good agreement 
with the published data (Fig. 6b and c). Notably, in rad30Δ cells, elongation efficiency was reduced to ~60% of 
the wild-type level. These observations are consistent with the results obtained from the RT-qPCR and luciferase 
assays shown in Fig. 5 and support a potential role of Polη in transcription elongation.
Polη is enriched over the actively transcribed GAL1 gene. Next we investigated whether Polη 
co-localized with transcriptionally active regions, as predicted by the above experiments. For this purpose we 
examined the enrichment of Myc-tagged Polη at the GAL1 gene relative to an intergenic region, using chromatin 
immunoprecipitation (ChIP) experiments41,42. To avoid detecting enrichment due to ongoing replication, cells 
were arrested in the G1 phase of the cell cycle (Fig. S9). Our results show that whereas a small, 2 fold increase 
could be detected at the upstream activating sequence (UAS) when shifting cells from raffinose to galactose, the 
level of Polη enrichment increased 5–8 fold over the open reading frame (ORF) of the GAL1 gene after transcrip-
tion induction (Fig. 6d). In contrast, no increase could be observed over a non-transcribed intergenic region. As 
controls, chromatin immunoprecipitations were performed with or without galactose induction in Gcn5-Myc 
and Spt5-Myc expressing as well as in non-tagged strains. In these experiments, as expected, the transcriptional 
co-activator histone acetyltransferase Gcn5 increased preferentially at the UAS (Fig. S9b), whereas the elongation 
factor Spt5 exhibited high enrichment over the ORF (Fig. S9c). In the non-tagged control strain, non-specific 
enrichment could not be detected. Taken together, these data show preferential enrichment of Polη over the ORF 
of the active GAL1 gene suggesting that Polη is specifically recruited to sites of active transcription.
The catalytic activity of Polη is involved in its role in transcription. The polymerase activity of Polη 
is essential for its known in vivo functions during DNA synthesis43. To address whether the polymerase activity 
of Polη was necessary for its new transcriptional role as well, we generated a strain expressing the catalytically 
inactive Polη D30A mutant from the genomic RAD30 locus. This was achieved by integrating back the wild-type 
or a mutant RAD30 copy coding for the D30A mutant protein into a rad30Δ strain. First, we verified by Western 
blot analysis that both the wild-type and mutant reintegrated genes expressed similar Polη levels (Fig. S10a). 
Next, we examined the sensitivity of the strains to different agents. As expected, reintegration of the wild-type 
sequence suppressed the UV and 6-AU sensitivities of the rad30Δ strain to the wild-type level confirming that 
both the enhanced UV and 6-AU sensitivities were indeed due to the lack of Polη (Fig. 7a). On the other hand, 
reintegration of the sequence coding for the D30A mutant protein rescued neither the UV nor the 6-AU sensitiv-
ity of the rad30Δ null mutant. Accordingly, the Polη D30A mutant negatively affected activation of GAL10 and 
GAL1 genes similarly to rad30Δ, whereas this was not the case for the reintegrated wild-type RAD30 (Fig. 7b and 
Fig. S10b). Importantly, chromatin immunoprecipitation experiments showed that the association of RNA PolII 
CTD with the active GAL1 gene was significantly reduced (p = 0.0015) at the 3′ end in the D30A mutant com-
pared to wild type, consistent with a defect in transcription elongation in this strain (Fig. 7c). In summary, these 
results indicate that the catalytic activity of Polη is required for its role in transcription.
Discussion
The results presented in this report uncover a specific RNA synthesis activity for the TLS DNA polymerase Polη. 
Furthermore, in vivo experiments establish a link between Polη and transcription.
The specificity of the novel RNA synthesis activity of Polη was assessed in steady-state kinetic experiments. 
This analysis revealed that Polη recognizes RNA as its substrate incorporating rNTPs into RNA an order of mag-
nitude more efficiently than into DNA. Furthermore, Polη could carry out TT dimer and 8-oxoG bypass during 
RNA extension by preferentially incorporating the correct A or C residue opposite the damage, respectively. These 
observations are paralleled by in vivo experiments supporting a connection between Polη and transcription. By 
measuring mRNA levels from inducible and constitutive promoters, we showed that transcription was generally 
diminished in the absence of Polη. This defect was independent of the DNA synthetic role of Polη as it could 
Insertion 
opposite
Incoming 
nucleotide kcat (min−1) Km (µM) kcat/Km
nucleotide 
concentrationa (µM)
Relative 
frequency
oxoG dCTP 1.7018 ± 0.1177 69.85 ± 18.53 24.36 E-03 14 19.4
oxoG rCTP 0.03424 ± 0.00358 973.97 ± 270.44 3.53 E-06 500
TT dimer dATP 4.9105 ± 0.5331 287.12 ± 83.85 17.10 E-03 16 18.6
TT dimer rATP 0.00831 ± 0.00106 1677.9 ± 444.8 4.95 E-06 3000
Table 4. Kinetic parameters of dNTP or rNTP incorporation by Polη into RNA opposite DNA damages. aIn 
vivo dNTP and rNTP concentrations are according to ref.14. Values were obtained from results shown in Fig. 4, 
and represent the mean and standard error of three experiments. Relative frequency was calculated using the 
formula as for Table 3.
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Figure 5. The absence of RAD30 affects transcription. (a) rad30Δ strains exhibit sensitivity to the elongation 
inhibitor 6-azauracil (6-AU) and (b) to mycophenolic acid (MPA). Ten fold serial dilutions of the strains with 
the indicated genotypes were spotted on media containing the indicated concentration of the appropriate drugs. 
(c) 6-AU induced mRNA level of the IMD2 gene and (d) galactose induced mRNA level of the GAL10 gene in 
the presence of MPA decreased in the rad30Δ strain, as measured by RT-qPCR. (e) Constitutive expressions 
of the UBC6 and (f) TRP3 genes in the presense of 6-AU are decreased in the absence of RAD30, as measured 
by RT-qPCR. (g) Firefly luciferase activity expressed from the induced GAL1 promoter is lowered in rad30Δ 
cells. (h) Renilla luciferase activity, driven from the constitutive GPD promoter, is diminished in the absence 
of RAD30. (i) Deletion of RAD30 causes transcriptional defect even in G1-arrested, NER defective cells, as 
measured by RT-qPCR. Panels (c–f and i) show relative mRNA levels measured by RT-qPCR normalized to 
SED1 mRNA. In panels (g,h) relative enzyme activities are presented. In panels (c–i) the values obtained for the 
wild-type strain were set to 100% and the values obtained with the deletion strains are shown relative to that. 
Data are presented as mean ± SD of at least 3 experiments. p values are indicated, ns: no statistical difference.
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Figure 6. Polη affects elongation in vivo and is enriched over the active GAL1 gene (a) Schematic drawing of 
the G-less based run-on (GLRO) assay. The sizes of the two G-less cassettes are shown. (b) GLRO analysis was 
performed with the indicated strains transformed with the GLRO-long plasmid. A representative gel picture 
is shown. See Fig. S8 for the full-length image. (c) Quantification of the results of four independent GLRO 
experiments. For each sample, the ratio of total counts incorporated into the distal versus the proximal G-less 
cassettes was normalized to the ratio in the wild-type strain, which was set to 100%. (d) Occupancy of Polη on 
the UAS, 5′ORF, 3′ORF of the GAL1 gene and on two independent intergenic regions in uninduced (raf) and 
induced (gal) conditions was measured by chromatin immunoprecipitation (ChIP) using anti-Myc antibody 
in a strain arrested in G1, and expressing C-terminally Myc-tagged Polη. As control, ChIP was also performed 
with an untagged strain (no tag). Percentage of input at the indicated regions was normalized to intergenic 
region 2 on chromosome IV. Experiments were repeated at least 3 times. Mean and standard deviations are 
indicated, p-values were calculated by 2-tailed t-test, n.s.: no statistical difference.
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be detected even when replication and repair synthesis were inhibited. Chromatin immunoprecipitation and 
in vivo transcription run-on assays demonstrated that Polη was enriched over the ORF of the active GAL1 gene 
and affected transcription elongation. Taken together the in vivo results suggest a role for Polη in transcription 
thereby providing a possible setting for its specific RNA synthesis activity. In particular, the observation that the 
catalytically inactive protein causes similar defects in transcription in vivo as the lack of Polη suggests that the 
newly discovered specific RNA synthesis activity of Polη contributes to transcription. Probably the most obvious 
reason for Polη being associated with transcription could be to rescue stalled RNAPII, particularly by inserting 
ribonucleotides opposite DNA lesions, similar to its role in rescuing damage-stalled replication. Although in vitro 
damage bypass studies showed that RNAPII could bypass several small, non-distorting lesions, such as abasic 
sites, dihydrouracil and 8-oxoG, resulting in mutagenic transcripts44–46, still, bulky damages and CPDs induced 
a complete block to RNAPII. In vivo bypass of these lesions in nucleotide excision repair (NER) defective cells 
further suggested the existence of damage bypass mechanisms operating during transcription47–53. So far transle-
sion RNA synthesis has been thought to be performed by RNAPII itself with the aid of elongation factors. Indeed, 
TFIIF, TFIIS, Elongin and CSB purified from HeLa cells were shown to help RNAPII to bypass certain oxidative 
DNA lesions54. Nevertheless, it remains elusive how RNAPII could bypass the high variety of lesions, and how it 
could overcome the blocks represented by CPDs and bulky damages. Based on our results, Polη could be a new 
candidate to help RNAPII to bypass DNA damage sites. However, our kinetic experiments demonstrated that 
Polη inserted dNTPs and rNTPs into RNA with similar efficiencies at intracellular nucleotide concentrations. 
Furthermore, though Polη could carry out error-free bypass of a TT dimer and 8-oxoG during RNA extension, 
damage bypass was an order of magnitude more efficient with dNTPs at intracellular nucleotide concentrations. 
These results indicate that if Polη participated in RNA synthesis in vivo, it could insert both rNTPs and dNTPs on 
undamaged templates, and it would most probably insert dNTPs opposite DNA lesions. This would have severe 
consequences by leading to the accumulation of dNTPs in RNA causing miscoding, affecting RNA structure55, 
RNA-protein interactions56, and RNA packaging57. To resolve this problem we presume that cellular factors can 
modify the kinetics of the reactions. Indeed, the DNA replication factor PCNA together with the clamp loader 
RFC and the ssDNA binding protein RPA were shown to stimulate the DNA synthetic activity of Polη with an 
order of magnitude on undamaged templates, and with two orders of magnitude opposite an abasic residue11,12. 
To get access to the nascent RNA, Polη is likely to form interactions with members of the elongation machinery, 
and as with its interaction with replication factors, these interactions could modulate the activity and/or selectiv-
ity of Polη so that rNTP insertion would be preferred opposite to undamaged as well as damaged bases.
Figure 7. Catalytic inactivation of Polη causes similar defects as the deletion of the RAD30 gene. (a) Strains 
carrying the Polη D30A mutant are sensitive to both UV and 6-AU. Ten fold serial dilutions of the indicated 
strains were spotted on media containing the indicated concentration of 6-AU, or irradiated with the indicated 
UV-dose after spotting. (b) Induced level of GAL10 mRNA is decreased in the Polη D30A mutant, as measured 
by RT-qPCR. The mean value obtained for the wild-type strain was set to 100% and the values obtained with 
the other strains are shown relative to that. (c) Occupancy of PolII in the Polη-Myc and the D30A Polη-Myc 
mutant expressing strains was measured with ChIP using anti-Myc antibody as described in Fig. 6d. Mean and 
standard deviations based on at least 4 experiments are indicated, p-values were calculated by 2-tailed t-test,n.s.: 
no statistical difference.
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Our hypothesis introduces a new concept: transcriptional DNA lesion bypass mediated by polymerase switch. 
Polymerase switch during transcription has long been ruled out because of the need for specific promoter ele-
ments to start transcription. Nevertheless, RNAPII has been shown to be able to pause, move backwards at stall 
sites, and transcription could be reactivated from the stalled state proving the elongating complex to be much 
more flexible than previously assumed58–60. We presume that this flexibility could support the consecutive steps of 
polymerase exchange at transcription complexes stalled at DNA damage sites.
Our hypothetical model could explain puzzling earlier observations detecting mammalian Polη foci forma-
tion after UV treatment in cells where replication and repair synthesis were inhibited61. Polη foci formation 
occurred in chinese hamster ovary and in human cell lines arrested in the G1 phase of the cell cycle. It was inde-
pendent of PCNA, and inactivation of NER did not influence Polη foci, either. Several studies demonstrated that 
transcription takes place at discrete foci in the nucleus called transcription factories62–64. We suggest that the tran-
scriptional role of Polη might be conserved through evolution and that the observed foci formation of mamma-
lian Polη could represent its recruitment to stalled transcription elongation complexes at transcription factories.
During the course of this work, a few studies have been published examining rNTP incorporation by yeast or 
human Polη. They showed that yeast Polη is very inefficient in extending a DNA primer with rNTPs20, whereas 
human Polη can extend a DNA primer with several rNTPs and even bypass DNA lesions such as 8-oxoG and TT 
dimers using ribonucleotides65,66. However, to our knowledge, the current study is the first showing specific RNA 
extension by a DNA polymerase and implicating this activity in transcription.
Methods
Yeast strains and plasmids. The wild-type strain BY4741 (MATa, his3-Δ1, leu2, met15, ura3) and its single 
deletion derivatives were obtained from the Euroscarf collection. Additional deletions were generated by gene 
replacement. Strains used in experiments involving synchronizing the cells in G1 phase were made bar1Δ to 
achieve complete and stable cell cycle arrest. For detection during chromatin immunoprecipitation, 9 copies of 
the Myc tag was fused to the C-terminus of the RAD30, GCN5, and SPT5 genes at the genomic locus by apply-
ing a PCR-based method67. To generate the mutant Polη protein, site-specific mutagenesis was carried out by a 
PCR based method according to the “Quick Change Site Directed Mutagenesis” protocol (Stratagene, La Jolla, 
California). Reintegration of wild-type or mutant RAD30 was done by transforming a linear DNA fragment con-
taining the RAD30 gene from −317 to 900 nucleotides after the stop codon, with the HIS3 marker gene inserted 
632 nucleotides downstream of the stop codon, into rad30Δ yeast cells. Genomic changes were confirmed by 
PCR and sequencing. The protease deficient yeast strain BJ5464 (MATα, his3-Δ200, leu2-Δ1, trp1Δ, ura3-52, 
pep4::HIS3, prb1-Δ1.6 R, can1) was used for protein overexpression (ATCC stock centre). pCYC-LacZ (GLRO-
Long) was used for GLRO assays40. The pY25GAL1-GPD dual promoter plasmid (Turbobiotech, Chang Cun, 
China) was used to clone the Renilla and Firefly luciferase genes under the GPD and GAL1 promoters, respec-
tively. The luciferase genes with the respective promoters and terminators were further cloned into the centro-
meric plasmid YCplac33 to generate plasmid pID723 used in the luciferase assays. For protein purification, the 
wild-type and the D30A mutant Polη were overexpressed as N-terminal fusions with the glutathione S-transferase 
(GST) gene from pID206 and pID797, respectively (pBJ842 backbone)68.
Polη purification. Wild-type and D30A mutant Polη were overexpressed in yeast as N-terminal fusions with 
GST and affinity purified on glutathione–Sepharose 4B beads (GE Healthcare) in a buffer containing 50 mM Tris/
HCl pH 7.0, 50 mM KCl, 100 mM NaCl, 10% sucrose, 0.5 mM EDTA, 10 mM 2-mercaptoethanol and protease 
inhibitors. After washing the column three times with 10X volume of a buffer containing 100 mM Tris/HCl pH 
7.5, 1 M NaCl, 0.01% NP40, 10% glycerol, and then two times with the same buffer but containing 100 mM NaCl, 
the GST-tag was removed in the last step of the purification by incubating the beads with PreScission protease in 
a buffer (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.01% Nonidet P-40, 10% glycerol) at 
4 °C for 12 hours.
Primer extension assays. Standard reactions (5 µl) contained 25 mM Tris/HCl pH 7.5, 5 mM MgCl2, 1 mM 
dithiothreitol, bovine serum albumin (100 µg/ml), 10% glycerol, and the specified amount of template and sub-
strate. Reactions were initiated by the addition of wild-type or mutant Polη at the indicated concentrations, incu-
bated at 30 °C and quenched by the addition of 10 µl loading buffer containing 95% formamide, 18 mM EDTA, 
0.025% SDS, 0.025% bromophenol blue and 0.025% xylene cyanol. The reaction products were resolved on 10% 
polyacrylamide gels containing 8 M urea and analyzed with a Typhoon TRIO Phosphorimager (GE Healthcare). 
Oligonucleotides used in these experiments were purchased from Integrated DNA Technologies, San Jose, 
California, except for the 8-oxoG containing primer that was from Midland Certified Reagent Co. Midland, 
Texas, and the TT-dimer containing oligonucleotide was from Trilink Biotechnologies, San Diego, California. 
Oligonucleotide sequences and the structures of substrates are shown in Table 1. To facilitate detection, oligonu-
cleotides labeled with the fluorophore indocarbocyanine (Cy3) at the 5′-ends were used as primers.
Determination of steady-state kinetic parameters. For steady-state kinetics of RNA and DNA primer 
extensions with rNTPs on undamaged templates, Polη (1 nM) was incubated with 20 nM of the DNA:DNA (S1-4)
or DNA:RNA (S5-8) templates in standard buffer (as above). For dNTP insertion into RNA, 1 nM Polη was 
incubated with 24 nM template in standard buffer. Reactions were initiated by adding the corresponding single 
rNTP (varied from 0.25 to 4 mM) or dNTP (25-1000 µM), and incubated at 30 °C from 30 sec to 60 min. The 
intensity of the gel bands corresponding to the substrate and the product were quantitated with Typhoon TRIO 
Phosphorimager (GE Healthcare) using ImageQuant TL software (GE Healthcare) and the observed rates of 
nucleotide incorporation were plotted as a function of rNTP concentration. The data were fit by nonlinear regres-
sion using SigmaPlot program (version 12.5 Systat Software, San Jose, CA) to the Michaelis-Menten equation 
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describing a hyperbola, v = (Vmax X [rNTP]/(Km + [rNTP]). The kcat and Km steady-state parameters were obtained 
from the fit and were used to calculate the efficiency of rNTP insertion into RNA versus DNA by using the follow-
ing equation: fext = (kcat/Km)RNA/(kcat/Km)DNA, and dNTP versus rNTP insertion into RNA according to the formula 
frel = (kcat1/Km1) * [dNTP]/(kcat2/Km2) * [rNTP]69.
Steady-state kinetic assay of DNA lesion bypass. For kinetic analysis of 8-oxoG bypass, 1 nM Polη 
was incubated with 8 nM template (S12) in standard buffer. Reactions were initiated by adding rCTP (0.25 to 
4 mM) or dCTP (25–1000 µM), and incubated at 30 °C for 30 min and 1 min, respectively. In case of TT dimer, 
1 nM Polη was incubated with 16 nM template (S16) in standard buffer. Reactions were initiated by adding rATP 
(0.25 to 4 mM) or dATP (25–1000 µM), and incubated at 30 °C for 60 min and 2 min, respectively. Reactions were 
visualized on 12% polyacrylamide gels containing 8 M urea and quantitated as above.
Sensitivity Assays. For 6-AU sensitivity assays, strains were transfected with YCplac33 (URA3 expressing 
plasmid) and cultures were grown overnight in synthetic complete (SC) media lacking uracil (-ura). From these 
starter cultures, 10X serial dilutions were spotted on SC-ura plates containing the respective amounts of 6-AU. 
MPA sensitivity was assayed similarly, but cells were grown in and spotted on SC media containing the indicated 
amount of MPA. Plates were incubated at 30 °C for 4–5 days. For UV sensitivity assays, 10X serial dilutions of 
overnight cultures grown in YPD (yeast-peptone-dextrose) medium were spotted on YPD plates, irradiated with 
the respective UV doses and incubated in the dark at 30 °C for 2–3 days.
Luciferase Assays. Strains transformed with pID723 and grown in SC-ura medium were used to measure 
luciferase activity using the dual luciferase reporter assay system (Promega Corporation, Madison, Wisconsin). 
Firefly luciferase expression was induced by addition of 2% galactose to cultures at a density of A600:0.7 and after 
1 h cells were harvested. To measure the constitutive expression of renilla luciferase, logarithmically growing cells 
at A600:0.7 were counted before measurements using a Bürker chamber, and activity was normalized to cell num-
ber. Luciferase measurements were carried out as described using a Fluoroskan Ascent FL microplate fluorometer 
and luminometer (Thermo Fischer Scientific Inc., Waltham, Massachusetts)70.
Analysis of mRNA levels by RT-qPCR. For measurement of IMD2, UBC6 and TRP3 mRNA levels, yeast 
strains transformed with YCplac33 were grown in SC-ura medium at 30 °C with vigorous shaking. At A600:0.5, 
6-AU was added to a final concentration of 70 µg/ml. After 2 h cells were collected and quickly frozen at −80 °C. 
For induction of GAL genes, yeast strains were grown in SC medium containing lactate as the sole carbon source 
(SCL). At A600:0.5, MPA was added to a final concentration of 70 µg/ml. After 2 h, galactose was added to a final 
concentration of 2% to induce GAL gene expression. 1 h after induction cells were collected and quickly frozen 
at −80 °C. For synchronization in the G1 phase of the cell cycle, exponentially growing strains carrying deletion 
of the BAR1 gene were synchronized at A600:0.4 in SCL by adding alpha mating factor (Sigma-Aldrich, St. Louis, 
MO, USA) to a final concentration of 50 ng/ml. Synchronization was checked microscopically. After 3 h MPA was 
added to a final concentration of 70 µg/ml, as well as more alpha factor to keep the cells in G1 phase. After 2 h with 
MPA, galactose was added to a final concentration of 2% and after another hour of incubation at 30 °C cells were 
pelleted and quickly frozen to −80 °C. Total RNA was purified using TRIzol Plus kit (Life Technologies, Carlsbad, 
California) according to the manufacturer’s protocol, except cells were disrupted with glass beads. On-column 
DNase treatment was performed for 20 minutes using PureLink DNase. Reverse transcription of 0.5 μg RNA was 
performed using oligo-dT primer and Revert Aid first strand cDNA synthesis kit (Thermo Fischer Scientific). 
Real-time qPCR was performed with SYBR-Green detection method on Light Cycler 480 (Hoffmann-La Roche, 
Basel, Switzerland) with the primers summarized in Table S1. The SED1 gene, whose mRNA level does not change 
significantly upon 6-AU or MPA treatment, or upon deleting RAD30, was used for normalization71.
G-less based run-on assay (GLRO). GLRO assays were carried out as previously described40,72. Briefly, the 
wild-type and mutant strains harboring the GLRO-long plasmid pCYC-LacZ were grown to an A600:0.5 in SC-leu 
at 30 °C. Cells were permeabilized with 0.5% sarkosyl for 20 min on ice. Pelleted cells were resuspended in 71 μl of 
ice-cold transcription mix (42.25 mM Tris/HCl pH 7.7, 422.5 mM KCl, 67.6 mM MgCl2, 1.13 mM ATP, 1.13 mM 
CTP, and 4.225 mM dithiothreitol). Labeling of nascent transcripts was initiated by the addition of 50 μCi of 
[α−32P]UTP (3,000 Ci/mmol), and samples were incubated for 5 min at 27 °C. “Chase” was performed with the 
addition of 10 μl of 25 mM UTP–0.25 mM GTP for 10 min at 27 °C. Reactions were stopped by addition of 900 μl 
of ice-cold AE buffer (50 mM sodium acetate, 10 mM EDTA pH 5.0). Total RNA was isolated using TRIzol (Life 
Technologies) and digested with RNaseT1, which only leaves G-less cassettes intact, for 2 h at 37 °C. After protein-
ase K treatment (Thermo Scientific), the remaining RNA was precipitated with ethanol as described, resuspended 
in formamide gel loading buffer (Life Technologies) and run on a 6% denaturing urea-acrylamide gel. Dried gels 
were analyzed with Typhoon TRIO Phosphorimager (GE Healthcare, Little Chalfont, UK) using ImageQuant TL 
software (GE Healthcare) as described40.
Chromatin immunoprecipitation (ChIP). For ChIP experiments, cells were exponentially grown at 
30 °C in SC + 2% raffinose medium to A600:0.6–0.8 and arrested in G1 during 4 h with alpha-factor (20 ng/ml). 
Synchronization efficiency was measured by FACS. To induce GAL1 gene expression 2% galactose was added to 
G1-arrested cells and cultures were grown for 1 h at 30 °C. Non-induced (2% raffinose) or induced (2% galactose) 
yeast cultures were cross-linked with 1% formaldehyde during 15 minutes and neutralized with 250 mM glycine 
during 5 min at room temperature followed by 10 min on ice. Cultures were pelleted and washed twice with cold 
PBS buffer. All subsequent procedures were done at 4 °C unless otherwise stated. Pellets were resuspended in FA 
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buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 
protease inhibitor cocktail (Roche)) and cells were disrupted with glass beads using a MagNA Lyser (4 times, 
6000 rpm). Recovered lysates were sonicated to obtain chromatin fragments with an average size of 250–500 nt 
and centrifuged for 15 min at 18000 g. The protein concentration of the supernatant was measured by Bradford 
and 1.5 mg of total cell extract was incubated overnight with antibodies (anti-Myc 9E10 or anti-CTD PolII 
8WG16 (Abcam)) and an additional 3 h with Dynabeads® Protein G (Thermo Fisher Scientific). After immu-
noprecipitation, beads were washed once with FA buffer, twice with FA buffer + 500 mM NaCl, twice with buffer 
III (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 250 mM LiCl, 1% NP-40, 1% sodium deoxycholate) and once with 
TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA). The immunoprecipitated material was eluted from the beads 
by two sequential incubations in 100 µl of buffer B (50 mM Tris-HCl, pH 7.5, 1% SDS, 10 mM EDTA) at 65 °C 
during 8 min. Proteinase K (Roth) was added to the eluted material and to input (10% of total IP volume set aside 
before antibody addition) to a final concentration 0.75 mg/ml and incubated at 42 °C for 2 h. De-crosslinking was 
done at 65 °C for 15 h followed by DNA purification by Wizard® SV Gel and PCR Clean-Up System (Promega). 
Quantification of total or precipitated DNA was done by RT-qPCR using SYBR® Green PCR Master Mix kit 
(Applied Biosystems) and primers listed in Table S2. Percentage of input for different regions was normalized to 
intergenic region 2 on the right arm of chromosome IV42.
Western blot analysis. For checking the expression level of Polη, 50 ml yeast cultures grown in YPD were 
harvested at A600: ~1.0. Whole cell extracts were prepared by a glass-bead lysis method in 1xPBS (137 mM NaCl, 
2.7 mM KCl, 10 mM Na2HPO4, 10 mM KH2PO4. 1 mM EDTA, 10% glycerol) with protease inhibitors. Cell lysates 
were quantified by Bradford. Equal amounts of whole cell lysates were separated by SDS-PAGE and analyzed by 
Western blotting using anti-Rad30 (sc-11868 Santa Cruz) and anti-PGK (Invitrogen A6457) primary antibodies, 
and anti-goat (sc-2020 Santa Cruz) and anti-mouse (Thermo Scientific 31430) secondary antibodies.
Statistical analysis. Student’s t-test using Excel (Microsoft, Redmond, WA, USA) was applied to compare 
separate groups. p-values of < 0.05 were considered statistically significant.
Data availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary Information files).
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